Blocking CNNM4 protein with RNA technology could treat rare and aggressive liver cancer
An international study led by Dr. Malu Martínez-Chantar, principal investigator at CIC bioGUNE and CIBERehd, has identified a new therapeutic target for cholangiocarcinoma (CCA), a rare but highly aggressive liver cancer ...
Sep 17, 2025
0
0









